160 related articles for article (PubMed ID: 12495477)
1. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Ono K; Takahashi A; Sakurai Y; Ohnishi K; Kobayashi T; Kinashi Y; Takagaki M; Ohnishi T
Jpn J Cancer Res; 2002 Dec; 93(12):1366-77. PubMed ID: 12495477
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
[TBL] [Abstract][Full Text] [Related]
3. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
Masunaga SI; Sanada Y; Takata T; Tanaka H; Sakurai Y; Suzuki M; Kirihata M; Ono K
J Radiat Res; 2023 Mar; 64(2):399-411. PubMed ID: 36763853
[TBL] [Abstract][Full Text] [Related]
4. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Suzuki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1163-70. PubMed ID: 9719128
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
[TBL] [Abstract][Full Text] [Related]
7. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
8. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
Masunaga S; Ono K; Sakurai Y; Suzuki M; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jan; 89(1):81-8. PubMed ID: 9510480
[TBL] [Abstract][Full Text] [Related]
9. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
[TBL] [Abstract][Full Text] [Related]
11. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):653-9. PubMed ID: 10701745
[TBL] [Abstract][Full Text] [Related]
12. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
16. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Nagata K; Suzuki M; Kinashi Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):570-7. PubMed ID: 15380594
[TBL] [Abstract][Full Text] [Related]
17. The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.
Masunaga SI; Uzawa A; Hirayama R; Matsumoto Y; Sakurai Y; Tanaka H; Tano K; Sanada Y; Suzuki M; Maruhashi A; Ono K
World J Oncol; 2015 Aug; 6(4):398-409. PubMed ID: 28983338
[TBL] [Abstract][Full Text] [Related]
18. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.
Masunaga S; Ono K; Takahashi A; Ohnishi T; Kinashi Y; Takagaki M
Eur J Cancer; 2002 Mar; 38(5):718-27. PubMed ID: 11916556
[TBL] [Abstract][Full Text] [Related]
20. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]